Newsletters
IAS Bi-monthly Newsletter
The IAS Newsletter is a monthly digest of the latest from IAS, including information submitted by our Constituent Member Societies. This service is provided to over 43,000 clinicians around the globe and delivered by email and social media. Access the current issue and archives of the newsletter below. Please contact the IAS office to offer any suggestions for inclusions.
Archive
-
2026
IAS Newsletter
-
2025
IAS Newsletter
-
2024
IAS Newsletter
-
2023
IAS Newsletter
-
2022
IAS Newsletter
-
2021
IAS Newsletter
Primary Prevention Newsletter
IAS’ Primary Prevention newsletter includes curated, peer-reviewed content about the effects, benefits, and harms of statins as related to atherosclerosis. Additional articles about lifestyle modifications, aspirin therapy, and new science related to alternatives for patients who are statin intolerant may also be included. Articles are curated and commentary is provided by Peter Lansberg, MD, PhD, a Dutch lipidologist, and a rotating panel of international experts. The newsletter’s editorial review is provided by Marcio Miname, MD, PhD, a physician and researcher at the Lipid Clinic at the Heart Institute in São Paulo. This program is supported in part by an independent medical educational grant from Mylan Inc., a Viatris Company.
Archive
-
2026 Primary Prevention
Monthly
-
2025 Primary Prevention
Monthly
-
2024 Primary Prevention
Monthly
-
2023 Primary Prevention
Monthly
-
2022 Primary Prevention
Monthly
-
Weekly
-
2021 Primary Prevention
Monthly
-
Weekly
Promoting the scientific understanding of atherosclerosis
Newsletters
-
The IAS e-Newsletter is a digest of the latest from the IAS and its Constituent Member Societies.
-
Going beyond statins, this resource provides the latest information about primary prevention for clinicians.